CRYO CELL INTERNATIONAL INC 8-K

What Happened

• On March 9, 2026, Cryo-Cell International, Inc. (ticker: CCEL) received a written notice from NYSE American LLC stating the company is not in compliance with the continued listing standards in Section 1003(a) of the NYSE American Company Guide. The company filed an 8-K and issued a press release on March 12, 2026. Trading of CCEL common stock continues on the NYSE American while the company pursues a plan to regain compliance.

Key Details

• Notice received: March 9, 2026 (filed in 8-K dated March 12, 2026).
• Plan deadline: Cryo-Cell intends to submit a plan of compliance by April 8, 2026 per NYSE American procedures.
• Trading status: No immediate effect on listing or trading; shares continue to trade under the symbol “CCEL.”
• Outcomes: If NYSE American accepts the plan, the exchange may grant an extension to regain compliance; there is no assurance the plan will be accepted or that the company will regain compliance within any extension.

Why It Matters

• This notice signals a regulatory listing risk that investors should monitor: failure to regain compliance could ultimately lead to delisting, while acceptance of a compliance plan could preserve the listing. Cryo-Cell is evaluating options and has set a formal deadline to submit its plan, so investors should watch for updates (including NYSE responses and any remedial steps the company announces).